glp1.how

access

Understanding insurance coverage for GLP-1 medications

Coverage for GLP-1 medications hinges on three levers — formulary, prior authorization, and step therapy — plus a fourth most people miss: whether the prescription is for diabetes or weight management. Here's how each actually works, and how to build your best case for coverage.

Understanding insurance coverage for GLP-1 medications

Getting a GLP-1 medication covered by insurance is rarely a simple yes-or-no. It usually comes down to a handful of specific mechanisms your plan uses to control cost and utilization — and understanding how each one works is the difference between guessing at the process and building a deliberate case for coverage.

The four things that determine your coverage

1. Formulary status and tier. The formulary is your plan's official list of covered drugs, organized into cost tiers (generic, preferred brand, non-preferred brand, specialty). GLP-1 medications are almost always placed in higher, more expensive tiers, and some formularies exclude them entirely for weight management while covering the identical drug for diabetes. For a full walkthrough of how to check your specific plan, see how to determine if your formulary covers GLP-1 medications — including who actually decides what's on that list.

2. Prior authorization. Prior authorization (PA) means your prescriber must submit documentation to the insurer justifying medical necessity before the plan will pay. For GLP-1 medications, this typically means proving a qualifying BMI threshold (often 27+ with a comorbidity, or 30+ alone), and sometimes documentation of prior weight-loss attempts. PA can take anywhere from a few days to several weeks, and is one of the most common points where a prescription stalls — not because it's been denied, but because required documentation is missing or incomplete.

3. Step therapy. Step therapy requires you to try and fail one or more lower-cost alternatives before the plan will cover the medication you and your prescriber actually want. For GLP-1s, this might mean documenting a trial of an older, cheaper weight-loss medication, or requiring you to try a specific GLP-1 (e.g., semaglutide) before a dual agonist like tirzepatide will be approved.

4. Diagnosis code: diabetes vs. weight management. This is the factor most people underestimate. The same drug (e.g., semaglutide) is sold under different brand names depending on indication — Ozempic for type 2 diabetes, Wegovy for weight management — and insurers frequently cover the diabetes indication far more readily than the weight-management one, even though the active ingredient is identical. If you have type 2 diabetes or prediabetes alongside excess weight, this distinction is worth discussing directly with your prescriber, since it can materially change your odds and speed of approval. Prescribing a drug for a use it isn't specifically labeled for is called off-label use, and it's a common reason for denial regardless of medical rationale.

How to check your own plan, step by step

  1. Confirm formulary status and tier for the exact drug and brand (see our detailed formulary-checking guide).
  2. Ask specifically whether prior authorization or step therapy applies, and request the plan's PA criteria document if available — this tells your prescriber exactly what to document.
  3. Confirm whether your plan covers the drug for your specific diagnosis (diabetes vs. weight management) — this can differ even within the same insurer.
  4. Ask about your copay, coinsurance, and where you stand relative to your deductible and out-of-pocket maximum, since these determine your real cost even once something is "covered."
  5. If you have employer-sponsored insurance, check with HR or benefits — some self-funded employers specifically exclude GLP-1 weight-management coverage regardless of what the insurer's standard formulary allows. See our guide on talking to your employer about GLP-1 coverage.

What to do if you hit a wall

  • If prior authorization is pending or unclear: ask your prescriber's office directly what documentation has been submitted and whether anything is missing — PA delays are frequently a paperwork gap rather than a denial.
  • If you're denied: you have the right to appeal. See our FAQ: My insurance denied coverage. What now?
  • If your plan requires step therapy you've already effectively completed (e.g., you tried a different weight-loss approach previously but it isn't well-documented), ask your prescriber whether that history can be submitted to satisfy the requirement.
  • If your employer plan excludes coverage entirely, your options shift toward manufacturer savings programs — see LillyDirect and NovoCare — or raising the exclusion directly with your employer's benefits team during open enrollment.

The bottom line

Coverage rules vary by plan, by employer, and by diagnosis — and they change often, sometimes year to year as formularies are renegotiated. Treat this guide as a framework for the right questions to ask, not a substitute for confirming the specifics directly with your insurer and prescriber. This is peer information, not medical or legal advice — for decisions about your specific treatment, talk with your care team.